John Palma is currently the Chief Medical Officer at Roche Sequencing. In his current role, he manages Clinical Science and Medical Affairs functions within disease areas and technologies. Prior to joining the Sequencing unit, John was the Medical Affairs Lead for Oncology at Roche Molecular where he supported companion diagnostic development of cobas ® assays. At Johnson & Johnson, he managed the discovery and early development teams for the identification of diagnostic biomarkers in oncology and diabetes. John earned his Ph.D. from the State University of New York in Brooklyn with a focus in the molecular biology. Over more than 20 years, he has published peer-reviewed manuscripts in diagnostics, drug target discovery and obtained patents in oncology, diabetes and molecular diagnostics.